BIM

News

bioMerieux buys microbiological analysis firm AES for $260M

Diagnostics company bioMerieux (PARIS:BIM) is acquiring French microbiological analysis company AES Laboratoire for $260 million. France-based bioMerieux, which has its U.S. headquarters in Durham, North Carolina, gains AES’ expertise in analyzing microbiological samples in industrial settings. The acquisition is bioMerieux’s ninth in five years. BioMerieux’s strength is in medical diagnostics and some of the company’s […]

By Frank Vinluan

News

bioMerieux partners with Ipsen on companion diagnostics for cancer

New personalized medicine cancer tests will be developed through a partnership announced between bioMerieux and Ipsen. Besides diagnosing disease, the companies expect the tests will also help speed development of new drugs to treat various cancers.

By Frank Vinluan

With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?

Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.